RSC Medicinal Chemistry

Papers
(The H4-Index of RSC Medicinal Chemistry is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Covalent cannabinoid receptor ligands – structural insight and selectivity challenges114
Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy82
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery68
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents58
Structure–activity relationship study of PROTACs against hematopoietic prostaglandin D2 synthase57
Synthesis and biological evaluation of novel D-ring fused steroidal N(2)-substituted-1,2,3-triazoles57
New azole derivatives linked to indole/indoline moieties combined with FLC against drug-resistant Candida albicans55
Metabolic labelling of cancer cells with glycodendrimers stimulate immune-mediated cytotoxicity54
N-Arylsulfonamide-based adenosine analogues to target RNA cap N7-methyltransferase nsp14 of SARS-CoV-250
Back cover43
Back cover41
Back cover41
Contents list41
Inside front cover38
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators37
In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape36
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibition33
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking31
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections29
Research progress of anticancer drugs targeting CDK1227
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation27
Biocompatible glycolipid derived from bhilawanol as an antibiofilm agent and a promising platform for drug delivery27
Identification of the first structurally validated covalent ligands of the small GTPase RAB27A26
Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure26
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer26
0.04525899887085